Fukuda Taiki, Nakamura Yusei, Tseng Shu-Chi, Ko Yuki, Gagne Staci M, Johkoh Takeshi, Li Yi, Christiani David C, Ojiri Hiroya, Sholl Lynette, Nishino Mizuki, Hatabu Hiroto
Center for Pulmonary Functional Imaging, Department of Radiology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Department of Radiology, The Jikei University School of Medicine, Tokyo, Japan.
JHLT Open. 2025 Feb 18;8:100232. doi: 10.1016/j.jhlto.2025.100232. eCollection 2025 May.
Restrictive chronic lung allograft dysfunction (CLAD) demonstrates poor outcomes after lung transplantation. However, the impact of radiological patterns on survival within a restrictive CLAD under the new International Society for Heart and Lung Transplantation (ISHLT) criteria remains unclear.
We analyzed retrospectively 241 bilateral lung transplant recipients between 2005 and 2021. CLAD was diagnosed and classified per the 2019 ISHLT criteria. Restrictive phenotype included restrictive allograft syndrome (RAS) and mixed phenotype. In these cases, RAS-like opacities (RLOs) were evaluated both qualitatively and semiquantitatively on computed tomography at CLAD diagnosis. RLOs were classified into upper-predominant and diffuse/lower-predominant distribution groups. Overall survival after CLAD diagnosis was assessed using Kaplan-Meier method with log-rank test and Cox proportional hazards models.
Eighty-three patients were diagnosed with CLAD after transplantation. Twenty-one (25.3%) had restrictive phenotype, which showed shorter survival compared to bronchiolitis obliterans syndrome (median survival: 19.8 vs 68.1 months; hazard ratio [HR], 4.53; 95% confidence interval [CI], 1.96-10.49; < 0.001). Within the restrictive phenotype, the upper-predominant group demonstrated longer survival than the diffuse/lower-predominant group (median survival: 61.1 vs 15.5 months; = 0.008). The diffuse/lower-predominant group had shorter survival compared to any other CLAD phenotype (HR, 8.45; 95% CI, 3.40-21.04; < 0.001). The extent of RLOs within each distribution pattern was not significantly associated with survival.
In restrictive phenotype CLAD, RLO distribution patterns determined survival outcomes, with diffuse/lower-predominant showing the poorest prognosis, while the extent of RLOs within each pattern did not correlate with prognosis.
限制性慢性肺移植功能障碍(CLAD)在肺移植后预后较差。然而,在新的国际心肺移植学会(ISHLT)标准下,放射学模式对限制性CLAD患者生存的影响仍不清楚。
我们回顾性分析了2005年至2021年间的241例双侧肺移植受者。根据2019年ISHLT标准诊断并分类CLAD。限制性表型包括限制性移植综合征(RAS)和混合表型。在这些病例中,在CLAD诊断时通过计算机断层扫描对RAS样混浊(RLOs)进行定性和半定量评估。RLOs分为上叶为主型和弥漫/下叶为主型分布组。采用Kaplan-Meier法、对数秩检验和Cox比例风险模型评估CLAD诊断后的总生存率。
83例患者移植后被诊断为CLAD。21例(25.3%)具有限制性表型,与闭塞性细支气管炎综合征相比,其生存期较短(中位生存期:19.8个月对68.1个月;风险比[HR],4.53;95%置信区间[CI],1.96 - 10.49;P < 0.001)。在限制性表型中,上叶为主型组的生存期比弥漫/下叶为主型组长(中位生存期:61.1个月对15.5个月;P = 0.008)。弥漫/下叶为主型组的生存期比任何其他CLAD表型都短(HR,8.45;95% CI,3.40 - 21.04;P < 0.001)。每种分布模式内RLOs的范围与生存率无显著相关性。
在限制性表型CLAD中,RLO分布模式决定生存结果,弥漫/下叶为主型预后最差,而每种模式内RLOs的范围与预后无关。